Author

Javier Gisbert

ORAL FERRIC MALTOL IMPROVES QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANAEMIA
ORAL FERRIC MALTOL IMPROVES QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANAEMIA

Javier Gisbert  et al.

EMPIRICAL VERSUS SUSCEPTIBILITY-GUIDED TREATMENT OF HELICOBACTER PYLORI INFECTION: A META-ANALYSIS
EMPIRICAL VERSUS SUSCEPTIBILITY-GUIDED TREATMENT OF HELICOBACTER PYLORI INFECTION: A META-ANALYSIS

Javier Gisbert

SAFETY OF THE TREATMENT OF H. PYLORI INFECTION: EXPERIENCE FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) ON 22,000 PATIENTS
SAFETY OF THE TREATMENT OF H. PYLORI INFECTION: EXPERIENCE FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG) ON 22,000 PATIENTS

Javier Gisbert

Update on treatment
Update on treatment

Javier Gisbert

EARLY PREDICTORS OF SURGERY IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: RESULTS OF AN INTERNATIONAL COHORT STUDY
EARLY PREDICTORS OF SURGERY IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: RESULTS OF AN INTERNATIONAL COHORT STUDY

Javier Gisbert  et al.

EMPIRICAL VERSUS SUSCEPTIBILITY-GUIDED TREATMENT OF HELICOBACTER PYLORI INFECTION: A META-ANALYSIS
EMPIRICAL VERSUS SUSCEPTIBILITY-GUIDED TREATMENT OF HELICOBACTER PYLORI INFECTION: A META-ANALYSIS

Javier Gisbert  et al.

THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS
THE EFFICACY AND SAFETY OF VONOPRAZAN IN DUAL/TRIPLE/QUADRUPLE REGIMENS BOTH IN FIRST-LINE AND RESCUE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A SYSTEMATIC REVIEW WITH META-ANALYSIS

Javier Gisbert  et al.

NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS
NON-BISMUTH QUADRUPLE CONCOMITANT TREATMENT FOR H. PYLORI ERADICATION: SYSTEMATIC REVIEW AND META-ANALYSIS

Javier Gisbert  et al.

ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY
ETROLIZUMAB VERSUS INFLIXIMAB FOR TREATING PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 GARDENIA STUDY

Javier Gisbert  et al.

CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN EUROPE DURING THE PERIOD 2013-2021: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN EUROPE DURING THE PERIOD 2013-2021: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Javier Gisbert  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN SPAIN DURING THE PERIOD 2013-2018
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN SPAIN DURING THE PERIOD 2013-2018

Javier Gisbert  et al.

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Javier Gisbert  et al.

PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA
PHENOTYPIC DIFFERENCES IN INFLAMMATORY BOWEL DISEASE BETWEEN WOMEN AND MEN: SEXEII STUDY OF ENEIDA

Javier Gisbert  et al.

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment
ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

Javier Gisbert  et al.

EFFICACY AND SAFETY OF PROACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING MAINTENANCE TREATMENT WITH ANTI-TNF AGENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
EFFICACY AND SAFETY OF PROACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE DURING MAINTENANCE TREATMENT WITH ANTI-TNF AGENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Javier Gisbert  et al.

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Javier Gisbert  et al.

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU
INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

Javier Gisbert  et al.

COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY
COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY

Javier Gisbert  et al.

PROFILING OF HUMAN CIRCULATING DENDRITIC CELLS AND MONOCYTES SUBSETS DISCRIMINATES TYPE AND MUCOSAL STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROFILING OF HUMAN CIRCULATING DENDRITIC CELLS AND MONOCYTES SUBSETS DISCRIMINATES TYPE AND MUCOSAL STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Javier Gisbert  et al.

GASTROGPT: FIRST SPECIALTY-SPECIFIC AI LANGUAGE MODEL OUTPERFORMS GENERAL MODELS ACROSS KEY CLINICAL TASKS
GASTROGPT: FIRST SPECIALTY-SPECIFIC AI LANGUAGE MODEL OUTPERFORMS GENERAL MODELS ACROSS KEY CLINICAL TASKS

Javier Gisbert  et al.

Item 1 - 20 / 107
1
2 3 4 5 6